Xinbang Pharmaceutical announced that the bribery crime case involving Guizhou Kekai Pharmaceutical Co., Ltd., a holding subsidiary of the company, has been tried and closed by the Kaiyang County People's Court of Guizhou Province. Kegai Pharmaceutical was fined 4 million yuan for the crime of bribery by the criminal unit. The company holds 99.9964% of Kekai Pharmaceutical's shares. The fine accounted for 3.33% of the company's most recent audited net profit to mother. The specific impact on the current period's profit is subject to the audit opinion. This judgment did not touch on major illegal forced delisting situations, and the company and its subsidiaries are operating normally on a daily basis.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.